Glucagon-like peptide-1(GLP-1), a peptide hormone secreted by intestinal L-cells, has broad pharmacological potential for managing type 2 diabetes mellitus and metabolic syndrome-related disorders by binding to its receptor -GLP-1R. The gene discussed is GCG; the disease is type 2 diabetes mellitus.